UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000047430
Receipt number R000054059
Scientific Title Clinical study on the effect of metyrosine on improving physiological and metabolic disorders in patients with pheochromocytoma/paraganglioma.
Date of disclosure of the study information 2022/04/11
Last modified on 2022/04/07 16:15:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical study on the effect of metyrosine on improving physiological and metabolic disorders in patients with pheochromocytoma/paraganglioma.

Acronym

Clinical study on the effect of metyrosine on improving physiological and metabolic disorders in patients with pheochromocytoma/paraganglioma.

Scientific Title

Clinical study on the effect of metyrosine on improving physiological and metabolic disorders in patients with pheochromocytoma/paraganglioma.

Scientific Title:Acronym

Clinical study on the effect of metyrosine on improving physiological and metabolic disorders in patients with pheochromocytoma/paraganglioma.

Region

Japan


Condition

Condition

pheochromocytoma/paraganglioma(PPGL)

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm efficacies of metyrosine administration in preoperative periods to the patients with PPGL.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Glucose metabolism(fasting blood glucose level,IRI,CPR,HOMA-beta,HOMA-IR)and decreased amount of catecholamines before and after administration of metyrosine.

Key secondary outcomes

Systolic and diastolic blood pressure and endocrine function (PRL, TSH, FT4, GH, IGF-1, PRA, PAC) before and after administration of metyrosine.
Blood pressure fluctuation, blood transfusion volume, urine volume, bleeding volume, phentolamine dose (mg), catecholamine usage before and after surgery.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Select the one that meets all of the following criteria
・Patients aged between 20 and 80 years old
・Patients who have given written consent to participate in the study.
However, if you have dementia or mental illness, the patient who obtained the consent of the substitute
・Patients who can or have undergone blood and urinalysis before and after PPGL treatment

Key exclusion criteria

Those who meet any of the following criteria are excluded from the target
・Patients with severe renal dysfunction(eGFR <30 mL/min)
・Lactating patients
・Patients judged by the principal investigator and the research coordinator to be inappropriate as research subjects

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Yuko
Middle name
Last name Matsuo

Organization

Kurume University School of Medicine

Division name

Department of Internal Medicine, Division of Endocrinology and Metabolism

Zip code

8300011

Address

67 Asahi-machi, Kurume city Fukuoka, JAPAN

TEL

0942317563

Email

matsuo_yuuko@med.kurume-u.ac.jp


Public contact

Name of contact person

1st name Yuko
Middle name
Last name Matsuo

Organization

Kurume University School of Medicine

Division name

Department of Internal Medicine, Division of Endocrinology and Metabolism

Zip code

8300011

Address

67 Asahi-machi, Kurume city Fukuoka, JAPAN

TEL

0942317563

Homepage URL


Email

matsuo_yuuko@med.kurume-u.ac.jp


Sponsor or person

Institute

Kurume University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics committee of Kurume University School of Medicine

Address

67 Asahi-machi, Kurume city Fukuoka, JAPAN

Tel

0942653749

Email

i_rinri@kurume-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

12

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 04 Month 01 Day

Date of IRB

2020 Year 10 Month 15 Day

Anticipated trial start date

2020 Year 10 Month 15 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The purpose of this study is to confirm the effectiveness of metyrosine administration for physiological, metabolic, and endocrinological functions in the preoperative period of PPGL patients compared to surgical treatment.


Management information

Registered date

2022 Year 04 Month 07 Day

Last modified on

2022 Year 04 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054059


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name